Valiant Laboratories Limited (VALIANTLAB.NS)
INR 100.59
(4.35%)
INR 100.59
(4.35%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.82 Billion INR | -45.48% |
| 2022 | 3.33 Billion INR | 14.54% |
| 2021 | 2.91 Billion INR | 59.85% |
| 2020 | 1.82 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 188.84 Million INR | -38.26% |
| 2023 Q2 | 595.46 Million INR | 15.83% |
| 2023 FY | 1.82 Billion INR | -45.48% |
| 2023 Q4 | 305.87 Million INR | -24.5% |
| 2023 Q3 | 405.15 Million INR | -31.96% |
| 2023 Q1 | 514.07 Million INR | -43.68% |
| 2022 FY | 3.33 Billion INR | 14.54% |
| 2022 Q4 | 912.69 Million INR | 28.96% |
| 2022 Q3 | 707.74 Million INR | -19.54% |
| 2022 Q2 | 879.58 Million INR | 0.0% |
| 2021 FY | 2.91 Billion INR | 59.85% |
| 2020 FY | 1.82 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Amrutanjan Health Care Limited | 4.21 Billion INR | 56.78% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -354.742% |
| Caplin Point Laboratories Limited | 16.76 Billion INR | 89.142% |
| FDC Limited | 19.42 Billion INR | 90.63% |
| Gufic Biosciences Limited | 8.06 Billion INR | 77.431% |
| Hikal Limited | 17.84 Billion INR | 89.798% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | 85.787% |
| IOL Chemicals and Pharmaceuticals Limited | 21.32 Billion INR | 91.464% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -17.934% |
| Medico Remedies Limited | 1.44 Billion INR | -25.625% |
| Nectar Lifesciences Limited | 16.84 Billion INR | 89.193% |
| Par Drugs and Chemicals Limited | 956.4 Million INR | -90.356% |
| RPG Life Sciences Limited | 5.82 Billion INR | 68.721% |
| Sequent Scientific Limited | 13.69 Billion INR | 86.709% |
| Shilpa Medicare Limited | 11.53 Billion INR | 84.212% |
| Sigachi Industries Limited | 3.98 Billion INR | 54.367% |
| Themis Medicare Limited | 3.81 Billion INR | 52.311% |
| Unichem Laboratories Limited | 16.57 Billion INR | 89.016% |
| Venus Remedies Limited | 5.91 Billion INR | 69.218% |
| Wanbury Limited | 5.75 Billion INR | 68.374% |
| ZIM Laboratories Limited | 3.67 Billion INR | 50.463% |
| Lupin Limited | 196.56 Billion INR | 99.074% |
| Innova Captab Limited | 10.81 Billion INR | 83.163% |
| Ind-Swift Limited | 5.02 Billion INR | 63.767% |
| Bajaj HealthCare Limited | 4.73 Billion INR | 61.544% |
| Aurobindo Pharma Limited | 290.01 Billion INR | 99.372% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | 85.299% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | 85.947% |
| Mangalam Drugs & Organics Limited | 3.67 Billion INR | 50.441% |
| Morepen Laboratories Limited | 17.01 Billion INR | 89.303% |
| Laurus Labs Limited | 50.01 Billion INR | 96.36% |
| Aarti Drugs Limited | 25.28 Billion INR | 92.8% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | 92.026% |
| Alembic Limited | 1.57 Billion INR | -15.603% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 97.021% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 98.459% |
| Vaishali Pharma Limited | 862.79 Million INR | -111.008% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | 89.972% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | 12.767% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 97.284% |
| Eris Lifesciences Limited | 20.09 Billion INR | 90.939% |
| Windlas Biotech Limited | 6.3 Billion INR | 71.146% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 99.625% |
| Lincoln Pharmaceuticals Limited | 5.8 Billion INR | 68.641% |
| Orchid Pharma Limited | 8.19 Billion INR | 77.781% |
| Albert David Limited | 3.62 Billion INR | 49.772% |
| Hester Biosciences Limited | 3.04 Billion INR | 40.22% |
| Sakar Healthcare Limited | 1.54 Billion INR | -18.091% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | 82.684% |
| Procter & Gamble Health Limited | 11.51 Billion INR | 84.186% |
| Divi's Laboratories Limited | 78.45 Billion INR | 97.679% |
| Mankind Pharma Limited | 103.34 Billion INR | 98.238% |
| Neuland Laboratories Limited | 15.58 Billion INR | 88.319% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | 94.719% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 99.043% |
| Wockhardt Limited | 27.89 Billion INR | 93.472% |
| Bal Pharma Limited | 3.39 Billion INR | 46.331% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 99.348% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | 76.364% |
| Alkem Laboratories Limited | 126.67 Billion INR | 98.563% |
| Ajanta Pharma Limited | 42.08 Billion INR | 95.674% |
| Bafna Pharmaceuticals Limited | 1.52 Billion INR | -19.409% |
| Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | 53.982% |
| Granules India Limited | 45.06 Billion INR | 95.96% |
| Medicamen Biotech Limited | 1.79 Billion INR | -1.534% |
| Ipca Laboratories Limited | 77.05 Billion INR | 97.637% |
| Brooks Laboratories Limited | 794.86 Million INR | -129.043% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | 29.774% |
| Piramal Enterprises Limited | 60.33 Billion INR | 96.983% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 98.283% |
| NATCO Pharma Limited | 40.02 Billion INR | 95.451% |
| Suven Life Sciences Limited | 116.92 Million INR | -1456.989% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -261.071% |
| Strides Pharma Science Limited | 40.51 Billion INR | 95.506% |
| Indoco Remedies Limited | 18.17 Billion INR | 89.982% |
| Alpa Laboratories Limited | 1.08 Billion INR | -67.426% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -74.493% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -140.991% |